← Back to Search

Behavioral Intervention

Enhanced DPP-GLB for Weight Loss Nonresponders

N/A
Recruiting
Research Sponsored by Lovoria Williams
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
non-diabetic
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months (at baseline, 12 weeks, 6 months)
Awards & highlights

Study Summary

This trial will help to establish the efficacy of identifying weight loss nonresponders early and providing them with more intense personalized strategies.

Who is the study for?
This trial is for Black individuals with a BMI of 25 or higher, at risk for diabetes but not yet diagnosed with Type 1 or Type 2 diabetes. Participants must live near the study sites and be able to engage in moderate physical activity. Pregnant individuals or those planning pregnancy during the study are excluded.Check my eligibility
What is being tested?
The trial tests an enhanced Diabetes Prevention Program (DPP-GLB Enhanced) against a standard version (DPP-GLB Standard). It aims to see if providing extra support through phone calls and resources helps those who initially don't lose weight in community-based settings.See study design
What are the potential side effects?
Since this intervention involves lifestyle changes rather than medication, side effects may include typical responses to diet change and increased physical activity such as muscle soreness, fatigue, or digestive adjustments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months (at baseline, 12 weeks, 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months (at baseline, 12 weeks, 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Weight at 12 Weeks
Change in Weight at 6 Months
Secondary outcome measures
Change in Blood Pressure at 12 Weeks
Change in Blood Pressure at 6 Months
Change in Dietary Intake at 12 Weeks
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: DPP-GLB StandardExperimental Treatment1 Intervention
Participants in this group will receive the standard Diabetes Prevention Program Group Lifestyle Balance (DPP-GLP) Intervention Program.
Group II: DPP-GLB EnhancedExperimental Treatment1 Intervention
Participants in this group will receive the enhanced Diabetes Prevention Program Group Lifestyle Balance (DPP-GLP) Intervention Program.

Find a Location

Who is running the clinical trial?

Lovoria WilliamsLead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,357 Previous Clinical Trials
4,314,686 Total Patients Enrolled
106 Trials studying Diabetes
138,163 Patients Enrolled for Diabetes

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people currently being recruited to participate in this clinical trial?

"Yes, the information on clinicaltrials.gov says that this clinical trial is presently recruiting candidates. The clinical trial was first posted on 2/18/2021 and was last edited on 11/14/2022. The study is searching for 500 participants at 5 sites in order to test the efficacy of the proposed treatment."

Answered by AI

How many people are expected to enroll in this study?

"That is accurate. The information available on clinicaltrials.gov reveals that this trial updated as recently as November 14th, 2022 and is still recruiting patients. They are looking for 500 individuals total, to be spread out across 5 different locations."

Answered by AI

What are the main goals of this medical study?

"The purpose of this 12-week clinical trial is to observe changes in weight at the 6-month mark. Other secondary objectives include studying the impact of weight on quality of life (as measured by the Impact of Weight on Quality of Life Questionnaire) and changes in physical activity and blood pressure at the 12-week mark."

Answered by AI

Who else is applying?

What site did they apply to?
Shiloh Baptist Church
What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

No luck with previous drugs.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.
Lovoria Williams 2021. "Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04757519.
All > Weight Loss Cincinnati
~96 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top